Perspective Therapeutics
CATX
30 hedge funds and large institutions have $1.18M invested in Perspective Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
3% more funds holding
Funds holding: 29 → 30 (+1)
0.4% less ownership
Funds ownership: 5.89% → 5.48% (-0.4%)
60% less capital inflows, than outflows
Capital inflows: $73.4K | Capital outflows: $186K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$24.5K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$9.16K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$8.96K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.21K |
| 5 |
Millennium Management
New York
|
+$7.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$152K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$25K |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$7K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.77K |
CATX Hedge Fund Activity: Q3 2019 in Review
30 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2019, worth a combined $1.18M — down 27% from $1.62M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CATX positions and 3 closed out — a net gain of 2 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $24.5K. The largest seller was Sabby Management, exiting entirely with an estimated $152K sold.
- 30 institutional investors held Perspective Therapeutics (CATX) as of Q3 2019, up from 29 in Q2 2019.
- Funds reported $1.18M of Perspective Therapeutics stock for Q3 2019, down 27% quarter-over-quarter.
- 5 funds opened new Perspective Therapeutics positions in Q3 2019 and 3 closed out, a net change of +2 holders.
- The largest Perspective Therapeutics buyer in Q3 2019 was Virtu Financial, an estimated $24.5K added.
- The largest Perspective Therapeutics seller in Q3 2019 was Sabby Management, an estimated $152K sold.
Based on aggregated 13F filings for Q3 2019.